Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Crinetics Pharmaceuticals, Inc. (CRNX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Exercised 10,000 options to buy
@ $1.91, valued at
$19.1k
|
|
| 07/13/2023 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 24,384 shares
@ $20.14, valued at
$491.1k
Sold 11,459 shares
@ $20.17, valued at
$231.1k
Sold 14,157 shares
@ $20.35, valued at
$288.1k
|
|
| 06/09/2023 |
4
| Vivaldi Coelho Rogerio (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Bought 5,000 shares
@ $22.06, valued at
$110.3k
|
|
| 04/05/2023 |
4
| Pizzuti Dana (Chief Development Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,288 shares
@ $15.98, valued at
$68.5k
Sold 8,212 shares
@ $16.15, valued at
$132.6k
|
|
| 03/17/2023 |
4
| Wilson Marc (CFO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,666 shares
@ $17.12, valued at
$28.5k
|
|
| 03/17/2023 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 4,628 shares
@ $17.12, valued at
$79.2k
|
|
| 03/17/2023 |
4
| Krasner Alan Seth (Chief Medical Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,687 shares
@ $17.12, valued at
$28.9k
|
|
| 03/17/2023 |
4
| Knight Jeff E. (COO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 587 shares
@ $17.12, valued at
$10k
|
|
| 03/17/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 1,410 shares
@ $17.12, valued at
$24.1k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 8,336 shares
@ $21.07, valued at
$175.6k
|
|
| 01/19/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 3,126 shares
@ $18, valued at
$56.3k
|
|
| 01/05/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 3,126 shares
@ $18.35, valued at
$57.4k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/14/2022 |
4
| Struthers Richard Scott (President & CEO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Exercised 11,100 options to buy
@ $1.91, valued at
$21.2k
|
|
| 10/11/2022 |
4
| Pizzuti Dana (Chief Development Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 shares
@ $0
Granted 230,000 options to buy
@ $16.89, valued at
$3.9M
|
|
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/19/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 4,168 shares
@ $21.01, valued at
$87.6k
|
|
| 09/09/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Sold 1,042 shares
@ $21.0017, valued at
$21.9k
|
|
| 09/06/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Acquired 1,336 shares
@ $11.02, valued at
$14.7k
Sold 3,126 shares
@ $18.59, valued at
$58.1k
|
|
| 07/29/2022 |
4
| Knight Jeff E. (COO) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Acquired 1,152 shares
@ $17.44, valued at
$20.1k
Sold 1,152 shares
@ $20.7004, valued at
$23.8k
|
|
| 07/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Nichols Weston (Director) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.|
Txns:
| Granted 17,500 options to buy
@ $18.29, valued at
$320.1k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|